IGEN Insider Trading - IGEN Networks Corp.

발행주식수	3,234,606,010 shares
내부자 지분	90,643,382 shares
내부자 주주	2.80 %
전체 내부자	5

내부자 센티멘트 점수

내부자 센티멘트 점수를 통해서 내부자들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

이는 내부자의 누적도가 가장 높은 기업을 식별하는 정교하고 복합적인 지수를 분석하는 계량 모델의 결과 값입니다. 스코어링 모델은 이전 90일 동안 매수한 "내부자의 순 숫자", "매수한 주식의 총합", "내부자가 소유한 주식의 총합"의 조합을 사용합니다. 점수는 0에서 100 사이이며, 점수가 높을수록 피어(Peer: 동종업계 경쟁기업)에 대한 누적도가 높다는 것을 나타내며, 평균은 50입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

가장 높은 순위의 주식을 확인하세요

내부 경영진 센티멘트 점수

내부 경영진 센티멘트 점수를 통해서 내부 경영진들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

내부 거래의 정의에 따라 내부 경영진(기업 임원)도 내부자이지만, 다른 내부자(10% 주주 및 이사회 구성원)들과는 달리 내부 경영진은 매일 회사에서 근무하며, 거래 시에 자신의 자금을 사용합니다. (많은 경우에 10% 주주 및 이사회 구성원은 다른 사람의 자금을 관리하는 자금 관리자입니다.) 따라서 내부 경영진(기업 임원: Officer)의 내부 거래는 훨씬 더 중요하며 올바른 분석이 필요합니다.

내부자 센티멘트 점수와 마찬가지로 임원 감정 점수는 가장 높은 수준의 임원 축적을 가진 기업을 식별하는 정교하고 복합적인 지수 퀀트(Multi-factor quantitative) 모델의 결과입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

가장 높은 순위의 주식을 확인하세요

주요 내부자 지표

이 수치는 해당 기업이 다양한 내부자 지표에 따라 어떻게 순위를 매겨지는 지를 설명합니다. 백분위 순위는 이 기업이 미국 시장의 다른 기업들과 어떻게 비교되는지 보여줍니다. 순위가 높을수록 더 나은 상황에 있다는 것을 의미합니다.

예를 들어, 일반적으로 내부자의 매입은 긍정적인 지표라고 간주되어지기 때문에, 내부자의 매입(내부자의 매각, 역시도)가 적은 기업보다 내부자의 매입이 많은 기업은 순위가 높을 것입니다.

내부자의 순 매입(순위)

0 ( )

7481 out of 10948

내부자의 순 매입(Net Number of Insiders Buying)는 내부자 매수의 총 수에서 지난 90일 동안의 내부자 매도의 총 수를 뺀 값입니다. 여기에 백분위 순위가 표시됩니다(범위: 0~100%).

내부자가 매입한 플로트 비율 (순위)

0.000% ( )

7386 out of 10786

"내부자가 매입한 플로트 비율(Percent of Float Bought by Insiders)"은 내부자가 매입한 주식의 총 수에서 내부자가 매도한 주식의 총 수를 뺀 값을 전체 플로트로 나눈 값에 100을 곱한 값입니다. * ((내부자가 매입한 주식의 총 수 - 내부자가 매도한 주식의 총 수) ÷ 전체 플로트) x 100

내부자 트레이딩 차트

IGEN Networks Corp. 내부자의 매매 거래는 아래 차트에 나와 있습니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다.

내부자의 명단 및 이익 지표

아래 표는 공개된 내부자의 목록이며, SEC에 공개된 제출 문서에서 자동으로 생성됩니다. "이름", "가장 최근의 직급", "이사, 임원 또는 10% 주주"에 대한 지정 외에도 최근에 공개된 보유 주식에 대한 정보를 보여줍니다. 또한 가능한 경우 내부자의 과거 거래 실적도 확인 가능합니다. 과거 거래 실적은 내부자가 실제 "공개 시장"(Open market) 매입 거래를 수행한 실적을 가중 평균한 값입니다. 이 계산 방법에 대한 자세한 내용은 유튜브 웨비나 를 참조하시면 됩니다.

See our leaderboard of most profitable insider traders.

내부자	평균 이익률 (%)	소유 지분	주식 분할
Neil Gene Chan CEO, Director - [D] [O]		27,726,911	27,726,911

내부자	평균 이익률 (%)	소유 지분	주식 분할
Richard Allan Freeman COO, Director - [D] [O]		474,900	474,900
Robert G Friedman Director, 10% Owner - [D] [10%]		50,000,000	50,000,000

내부자	평균 이익률 (%)	소유 지분	주식 분할
Robert Nealon Director - [D]		2,271,571	2,271,571
Abel Israel Sr Sierra Vice President - [O]		10,170,000	10,170,000

Report errors via our new Insider Auditing Tool

내부자의 매입 내역 추적: 단기 이익 분석

이 섹션에서는 IGEN / IGEN Networks Corp.에서 계획되지 않은 "공개 시장"(Open market)의 내부자가 매입한 모든 상품의 수익성을 분석합니다. 이 분석을 통해서 내부자가 비정상적인 수익을 지속적으로 창출하는지 파악하는 데 도움이 되며, 이러한 분석은 수행해볼 가치가 있습니다. 이 분석은 개별 거래 후 1년 동안 수행한 것이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 "공개 시장"(Open market)에서의 매입을 보여줍니다.

거래일	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최고까지 일수	최고에서 가격	최고 이익 ($)	최고 수익률 (%)
2020-11-20	Chan Neil Gene	150,000	0.0051	150,000	0.0051	765	94	0.0216	2,475	323.53
2020-11-19	Chan Neil Gene	200,000	0.0055	200,000	0.0055	1,100
2020-11-18	Chan Neil Gene	150,000	0.0048	150,000	0.0048	720
2020-10-01	Chan Neil Gene	200,000	0.0080	200,000	0.0080	1,600
2020-09-30	Chan Neil Gene	200,000	0.0083	200,000	0.0083	1,660
2020-07-31	Chan Neil Gene	200,000	0.0074	200,000	0.0074	1,480
2020-06-03	Sierra Abel Israel Sr	10,000,000	0.0025	10,000,000	0.0025	25,000
2020-06-01	Chan Neil Gene	16,828,800	0.0025	16,828,800	0.0025	42,072
2020-04-17	Chan Neil Gene	500,000	0.0080	500,000	0.0080	4,000

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

IGEN / IGEN Networks Corp. Insider Trades

내부자 매매의 실적: 단기 손실 분석

이 섹선에서는 IGEN / IGEN Networks Corp.에서 이루어진 "공개 시장(Open market)"에서의 모든 계획되지 않은 내부자 매매의 단기 손실 회피(Short-term loss avoidance)를 분석합니다. 일관된 손실 회피 패턴을 통해서 향후 매매 거래가 가격 하락을 초래할 수도 있음을 예상할 수 있습니다. 이 분석은 각 각 매매 거래 후 1년 동안의 자료이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장에서의 매매를 보여줍니다.

거래일	내부자	보고된 지분	보고된 가격	조정된 지분	조정된 가격	가격 기준	최저까지 일수	최저에서 가격	회피된 최대 손실($)	회피된 최대 손실율(%)
2019-08-23	Chan Neil Gene	20,000	0.0450	20,000	0.0450	900	235	0.0006	-888	-98.67
2015-09-10	Chan Neil Gene	270,000	0.2100	270,000	0.2100	56,700

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

거래 내역

전체 거래 내역을 보려면 링크 아이콘을 클릭하세요. 10b5-1 자동 거래 계획의 일부로 보고된 거래는 10b-5 열에 X 표시가 나타납니다.

보고일	거래일	양식	내부자	티커	증권 소유권	코드	직접	행사 가격	단위 가격	단위 변동	가치 변동 (단위: 1,000)	잔여 옵션	잔여 주식
2020-11-23	2020-11-20	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0051	150,000	1		27,726,911
2020-11-23	2020-11-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0055	200,000	1		27,576,911
2020-11-23	2020-11-18	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0048	150,000	1		27,376,911
2020-10-01	2020-10-01	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0080	200,000	2		27,226,911
2020-10-01	2020-09-30	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0083	200,000	2		27,026,911
2020-07-31	2020-07-31	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0074	200,000	1		26,826,911
2020-06-04	2020-06-03	4	Sierra Abel Israel Sr	IGEN	Common Stock	P - Purchase	D		0.0025	10,000,000	25		10,170,000
2020-06-01	2020-06-01	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0025	16,828,800	42		26,626,911
2020-04-17	2020-04-17	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0080	500,000	4		9,798,111
2020-04-17	2020-04-16	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0090	500,000	4		9,298,111
2020-04-17	2020-04-15	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0070	2,000,000	14		8,798,111
2020-04-17	2020-04-14	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0070	1,000,000	7		6,798,111
2020-04-10	2020-04-09	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0010	1,000,000	1		5,798,111
2020-04-10	2020-04-08	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0012	500,000	1		4,798,111
2020-03-30		3	Friedman Robert G	IGEN	Common Stock		D						50,000,000
2020-03-30		3	Friedman Robert G	IGEN	Common Stock		D						50,000,000
2020-03-30		3	Friedman Robert G	IGEN	Common Stock		D						50,000,000
2020-03-27	2020-02-13	5	Nealon Robert	IGEN	Common Stock	P - Purchase	D		0.0150	1,750,000	26		2,271,571
2020-03-23	2020-03-23	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0011	500,000	1		4,298,111
2020-03-23	2020-03-20	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0015	500,000	1		3,798,111
2020-02-24	2020-02-24	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0050	200,000	1		3,298,111
2020-02-24	2020-02-21	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0064	300,000	2		3,098,111
2020-02-24	2020-02-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0095	50,000	0		2,798,111
2020-02-24	2020-02-18	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0085	100,000	1		2,748,111
2020-02-13	2020-02-12	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0100	50,000	0		2,648,111
2020-02-13	2020-02-11	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0110	100,000	1		2,598,111
2020-02-13	2020-02-07	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0140	100,000	1		2,498,111
2020-02-13	2020-02-06	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0140	50,000	1		2,398,111
2019-12-20	2019-12-20	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0180	25,000	0		2,348,111
2019-12-20	2019-12-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0180	25,000	0		2,323,111
2019-12-20	2019-12-17	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0180	100,000	2		2,298,111
2019-12-20	2019-12-16	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0190	25,000	0		2,198,111
2019-12-13	2019-12-11	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0250	25,000	1		2,173,111
2019-12-13	2019-12-10	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0250	10,000	0		2,148,111
2019-12-13	2019-12-09	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0250	50,000	1		2,138,111
2019-12-05	2019-12-04	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.3100	25,000	8		2,088,111
2019-12-05	2019-12-03	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.3000	25,000	8		2,063,111
2019-11-20	2019-11-20	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0310	5,000	0		2,038,111
2019-11-20	2019-11-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0340	5,000	0		2,033,111
2019-11-20	2019-11-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0250	50,000	1		2,028,111
2019-11-20	2019-11-18	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0370	30,000	1		1,978,111
2019-10-31	2019-10-31	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0380	5,000	0		1,948,111
2019-10-31	2019-10-31	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0330	75,000	2		1,943,111
2019-10-31	2019-10-29	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0300	20,000	1		1,868,111
2019-10-31	2019-10-28	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0400	5,000	0		1,848,111
2019-08-29	2019-08-29	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0600	10,000	1		1,843,111
2019-08-29	2019-08-28	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0390	20,000	1		1,833,111
2019-08-26	2019-08-23	4	Chan Neil Gene	IGEN	Common Stock	S - Sale	D		0.0450	-20,000	-1		1,813,111
2019-08-26	2019-08-21	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0400	10,000	0		1,833,111
2019-02-22	2019-02-21	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0400	45,000	2		1,823,111
2019-02-22	2019-02-15	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0350	50,000	2		1,778,111
2019-02-22	2019-02-12	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0400	25,000	1		1,728,111
2019-02-22	2019-02-12	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0400	25,000	1		1,728,111
2019-01-17	2019-01-17	4	Chan Neil Gene TFSA Neil Chan	IGEN	Common Stock	J - Other	I			300,000			654,278
2019-01-17	2019-01-17	4	Chan Neil Gene	IGEN	Common Stock	J - Other	D			-300,000			1,678,111
2019-01-10	2019-01-09	4	Chan Neil Gene TFSA Heather M. Chan	IGEN	Common Stock	J - Other	I			182,678			354,278
2019-01-10	2019-01-09	4	Chan Neil Gene TFSA Neil Chan	IGEN	Common Stock	J - Other	I			182,678			354,278
2019-01-10	2019-01-09	4	Chan Neil Gene	IGEN	Common Stock	J - Other	D			-365,356			1,978,111
2018-11-13	2018-11-06	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0900	2,000	0		2,343,467
2018-11-13	2018-11-05	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0850	2,500	0		2,341,467
2018-11-13	2018-11-05	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0610	5,000	0		2,338,967
2018-11-08	2018-11-08	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0850	2,000	0		2,333,967
2018-11-08	2018-11-08	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0599	2,000	0		2,331,967
2018-11-08	2018-11-06	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0900	2,000	0		2,329,967
2018-11-08	2018-11-05	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0850	2,500	0		2,327,967
2018-11-08	2018-11-05	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0610	5,000	0		2,325,467
2018-10-12	2018-10-12	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0800	2,000	0		2,320,467
2018-10-12	2018-10-12	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0620	3,000	0		2,318,467
2018-08-31	2018-08-31	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0800	5,000	0		2,315,467
2018-08-31	2018-08-30	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0650	5,000	0		2,310,467
2018-08-17	2018-08-16	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0700	500	0		2,305,467
2018-08-17	2018-08-16	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0850	2,000	0		2,304,967
2018-08-17	2018-08-15	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0650	5,000	0		2,302,967
2018-08-17	2018-08-15	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0550	5,000	0		2,297,967
2018-08-10	2018-08-09	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0570	2,500	0		2,292,967
2018-08-10	2018-08-09	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0700	2,000	0		2,290,467
2018-08-10	2018-08-09	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0650	3,000	0		2,288,467
2018-08-10	2018-08-08	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0510	2,500	0		2,285,467
2018-08-10	2018-08-08	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0600	5,000	0		2,282,967
2018-07-20	2018-07-17	4	Sierra Abel Israel Sr	IGEN	Common Stock	P - Purchase	D		0.0400	20,000	1		170,000
2018-07-20		3	Sierra Abel Israel Sr	IGEN	Common Stock		D						300,000
2018-07-20		3	Sierra Abel Israel Sr	IGEN	Common Stock		D						300,000
2018-07-20		3	Sierra Abel Israel Sr	IGEN	Common Stock		D						300,000
2018-07-17	2018-07-16	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0550	5,000	0		2,277,967
2018-06-29	2018-06-29	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0700	5,000	0		2,262,967
2018-06-29	2018-06-27	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0400	10,000	0		2,257,967
2018-06-20	2018-06-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0400	10,000	0		2,257,967
2018-04-06	2018-04-06	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1150	2,500	0		2,247,967
2018-04-06	2018-04-05	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0600	10,000	1		2,245,467
2018-03-26	2018-03-23	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0600	5,000	0		2,235,467
2018-03-26	2018-03-22	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0600	5,000	0		2,230,467
2018-03-26	2018-03-21	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1150	2,000	0		2,225,467
2018-01-22	2018-01-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0998	5,000	0		2,223,467
2018-01-12	2018-01-09	4	Chan Neil Gene TFSA Neil Chan	IGEN	Common Stock	J - Other	I			171,600			171,600
2018-01-12	2018-01-09	4	Chan Neil Gene TFSA Heather M. Chan	IGEN	Common Stock	J - Other	I			171,600			171,600
2018-01-12	2018-01-09	4	Chan Neil Gene	IGEN	Common Stock	J - Other	D			-343,200			2,218,467
2018-01-12	2018-01-04	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1194	5,000	1		2,561,667
2018-01-12	2017-12-15	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0700	2,000	0		2,556,667
2018-01-12	2017-12-15	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0700	2,000	0		2,556,667
2018-01-12	2017-12-04	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1150	2,000	0		2,552,667
2018-01-12	2017-11-29	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1000	2,000	0		2,550,667
2018-01-12	2017-11-28	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1000	2,000	0		2,548,667
2017-09-22	2017-09-21	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0850	2,500	0		2,546,667
2017-09-22	2017-09-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1140	2,500	0		2,544,167
2017-09-22	2017-09-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0970	2,500	0		2,541,667
2017-09-19	2017-09-15	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0750	2,000	0		2,539,167
2017-09-19	2017-09-14	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0650	20,000	1		2,537,167
2017-09-19	2017-09-14	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0700	1,000	0		2,517,167
2017-09-19	2017-09-14	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0950	2,000	0		2,516,167
2017-09-06	2017-09-01	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0850	11,000	1		2,514,167
2017-09-06	2017-09-01	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1000	10,000	1		2,503,167
2017-06-20	2017-06-14	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1000	10,000	1		2,553,167
2017-05-19	2017-05-11	4	Freeman Richard Allan	IGEN	Options	A - Award	D	0.13		500,000		1,775,000
2017-05-19	2017-05-11	4	Chan Neil Gene	IGEN	Options	A - Award	D	0.13		500,000		1,500,000
2017-05-15	2017-05-11	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1300	6,000	1		2,543,167
2017-05-15	2017-05-10	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1300	4,000	1		2,549,167
2017-05-09	2017-04-18	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1300	5,000	1		2,548,167
2017-04-20	2017-04-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1400	2,500	0		2,553,167
2017-04-20	2017-04-19	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1230	2,500	0		2,550,667
2017-01-20	2017-01-18	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0950	5,000	0		2,523,167
2017-01-20	2017-01-18	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1000	5,000	0		2,518,167
2017-01-13	2017-01-09	4	Chan Neil Gene	IGEN	Common	P - Purchase	D		0.0600	25,000	2		2,513,167
2017-01-13	2017-01-06	4	Chan Neil Gene	IGEN	Common	P - Purchase	D		0.0749	10,000	1		2,488,167
2016-12-16	2016-12-12	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0700	10,000	1		2,478,167
2016-12-16	2016-12-09	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.1000	10,000	1		2,468,167
2016-10-05	2016-09-26	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0910	25,000	2		2,458,167
2016-07-20	2016-07-12	4	Chan Neil Gene	IGEN	Common	P - Purchase	D		0.1380	5,000	1		2,433,167
2016-05-12	2016-05-05	4	Chan Neil Gene	IGEN	Common	P - Purchase	D		0.1550	10,000	2		2,428,167
2016-02-25	2016-02-12	4	Chan Neil Gene	IGEN	Common	P - Purchase	D		0.1800	10,000	2		2,418,167
2016-02-25	2016-02-10	4	Chan Neil Gene	IGEN	Common	P - Purchase	D		0.1780	10,000	2		2,408,167
2016-02-25	2016-02-09	4	Chan Neil Gene	IGEN	Common	P - Purchase	D		0.1740	10,000	2		2,398,167
2016-02-25	2016-01-07	4	Chan Neil Gene	IGEN	Options	M - Exercise	D	0.09	0.0900	-55,556	-5	0
2016-02-25	2016-01-07	4	Chan Neil Gene	IGEN	Common	M - Exercise	D		0.0900	55,556	5		2,388,167
2015-10-07	2015-09-21	4	Nealon Robert	IGEN	Options	A - Award	D	0.19		250,000		250,000
2015-10-02	2015-09-21	4	Freeman Richard Allan	IGEN	Options	A - Award	D	0.19		1,000,000		1,000,000
2015-10-02	2015-09-21	4	Chan Neil Gene	IGEN	Options	A - Award	D	0.19		1,000,000		1,000,000
2015-09-14	2015-09-10	4	Chan Neil Gene	IGEN	Common Stock	S - Sale	D		0.2100	-270,000	-57		2,332,611
2015-09-14	2015-09-10	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.2500	5,500	1		2,602,611
2014-04-15	2014-03-05	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0800	25,000	2		249,900
2014-04-15	2014-03-03	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0650	5,000	0		224,900
2014-04-15	2014-02-28	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0650	52,000	3		219,900
2014-04-15	2014-02-27	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0650	25,000	2		167,900
2014-04-15	2014-02-27	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0650	5,000	0		142,900
2014-04-15	2014-01-27	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0900	9,000	1		137,900
2014-04-15	2014-01-14	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0950	10,000	1		128,900
2014-04-15	2013-12-13	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1050	6,000	1		118,900
2014-04-15	2013-12-04	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1100	5,500	1		112,900
2014-04-15	2013-12-02	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1200	10,000	1		107,400
2014-04-15	2013-11-29	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1300	5,000	1		97,400
2014-04-15	2013-11-27	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1300	5,000	1		92,400
2014-04-15	2013-11-27	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.0950	5,000	0		87,400
2014-04-15	2013-11-26	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1030	10,000	1		82,400
2014-04-15	2013-11-22	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1000	10,000	1		72,400
2014-04-15	2013-10-11	5	Freeman Richard Allan	IGEN	Stock Option	C - Conversion	D	0.09	0.0900	-225,000	-20	275,000
2014-04-15	2013-10-11	5	Freeman Richard Allan	IGEN	Common Stock	C - Conversion	D		0.0900	225,000	20		474,900
2014-04-15	2013-03-25	5	Freeman Richard Allan	IGEN	Stock Option	A - Award	D	0.09	0.0900	500,000	45	500,000
2014-04-15	2012-11-02	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1000	4,998	0		62,400
2014-04-15	2012-10-26	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1000	5,000	0		57,402
2014-04-15	2012-10-16	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1290	5,500	1		42,402
2014-04-15	2012-10-16	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1250	5,000	1		36,902
2014-04-15	2012-10-16	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1230	11,900	1		31,902
2014-04-15	2012-10-15	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1300	10,000	1		52,402
2014-04-15	2012-10-15	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1000	2	0		20,002
2014-04-15	2012-09-12	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1500	10,000	2		20,000
2014-04-15	2012-09-12	5	Freeman Richard Allan via 3rd party account with direct control; not an admission of beneficial ownership	IGEN	Common Stock	P - Purchase	I		0.1700	10,000	2		10,000
2014-04-15	2014-02-28	5	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0650	21,000	1		2,597,111
2014-04-15	2014-02-27	5	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0650	70,000	5		2,576,111
2014-04-15	2013-11-04	5	Chan Neil Gene	IGEN	Stock Option	C - Conversion	D	0.09	0.0900	-325,000	-29	55,556
2014-04-15	2013-11-04	5	Chan Neil Gene	IGEN	Common Stock	C - Conversion	D		0.0900	325,000	29		2,506,111
2014-04-15	2013-08-01	5	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0895	10,000	1		2,181,111
2014-04-15	2013-07-31	5	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0895	13,000	1		2,171,111
2014-04-15	2013-07-30	5	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0995	12,000	1		2,156,111
2014-04-15	2013-07-29	5	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		0.0833	15,000	1		2,146,111
2014-04-15	2013-03-26	4/A	Chan Neil Gene	IGEN	Options	M - Exercise	D	0.09	0.0900	-444,444	-40	380,556
2014-04-15	2013-03-26	4/A	Chan Neil Gene	IGEN	Common Stock	M - Exercise	D		0.0900	444,444	40		2,131,111
2014-04-15	2013-03-25	4/A	Chan Neil Gene	IGEN	Options	A - Award	D	0.09	0.0900	825,000	74	825,000
2013-04-11	2013-03-26	4	Chan Neil Gene Shares owned by shareholders company	IGEN	Options	M - Exercise	I	0.09	0.0900	-444,444	-40	55,556
2013-04-11	2013-03-26	4	Chan Neil Gene Shares owned by shareholders' company	IGEN	Common Stock	M - Exercise	I		0.0900	444,444	40		444,444
2013-03-19	2013-03-18	4	Chan Neil Gene	IGEN	Common Stock	A - Award	D			1,666,667			1,686,667
2012-08-03	2012-07-09	4	Chan Neil Gene	IGEN	Common Stock	P - Purchase	D		5,999.1500	20,000	119,983		20,000

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입

공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각

자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득

파생상품 전환

자사에게 유가증권을 매각 또는 양도

기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급

내부자에 의한 또는 내부자에게 증권 증여

지분스왑 및 유사 위험 회피거래

자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환

보고서 양식 4에 자진 신고된 거래

기타 (거래 내용을 설명하는 각주와 동반)

IGEN / IGEN Networks Corp. - Insider Trading and Ownership Report - SEC Form 3, 4, 5